🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to find out whether an experimental autologous ...
Status
Completed
Location
Infectious Disease Unit; Massachusetts General Hospital
Start Date
2009-08
Trial ID
NCT00833781
RATIONALE: Vaccines made from a patient's white blood cells (dendritic cell...
Status
Completed
Location
Antwerp University Hospital/Center for Cellular Therapy and Regenerative Medicine
Start Date
2005-03
Trial ID
NCT00834002
Treatments Being Tested
The purpose of this research is to develop a new and powerful type of immun...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT01153113
Treatments Being Tested
This is a randomized phase II trial including 40 patients with castration r...
Status
Completed
Location
Center for Cancer Immune Therapy, Dept. of Haematology/Oncology
Start Date
2011-10
Trial ID
NCT01446731
Treatments Being Tested
The aim of this study is to determine the feasibility and safety of an auto...
Status
Completed
Location
Hospital of the University of Munich, LMU; Department od Medicine III
Start Date
2013-11-05
Trial ID
NCT01734304
Treatments Being Tested
1. Rationale Immunotherapy applying ex vivo generated and tumor antigen...
Status
Terminated
Location
Radboud University Nijmegen Medical Centre
Start Date
2009-06
Trial ID
NCT00929019
Treatments Being Tested
This is a phase II study to evaluate the safety, feasibility and efficacy o...
Status
Completed
Location
Emory University School of Medicine
Start Date
2007-07
Trial ID
NCT00510133
Treatments Being Tested
In this trial the investigators want to combine chemotherapy with immunothe...
Status
Terminated
Location
The Norwegian Radium Hospital, Department of Clinical Cancer Research
Start Date
2009-08
Trial ID
NCT00961844
Dendritic cells (DCs)are the most potent antigen-presenting cells of the im...
Status
Completed
Location
Radboud University Nijmegen Medical Center
Start Date
2004-04
Trial ID
NCT00243529
Treatments Being Tested